HLA Ligand Atlas: a benign reference of HLA-presented peptides to improve T-cell-based cancer immunotherapy.

Saved in:
Bibliographic Details
Title: HLA Ligand Atlas: a benign reference of HLA-presented peptides to improve T-cell-based cancer immunotherapy.
Authors: Marcu A; Department of Immunology, Interfaculty Institute for Cell Biology, University of Tübingen, Tübingen, Germany ana@hla-ligand-atlas.org.; Cluster of Excellence iFIT (EXC 2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tübingen, Germany., Bichmann L; Department of Immunology, Interfaculty Institute for Cell Biology, University of Tübingen, Tübingen, Germany.; Applied Bioinformatics, Department of Computer Science, University of Tübingen, Tübingen, Germany., Kuchenbecker L; Applied Bioinformatics, Department of Computer Science, University of Tübingen, Tübingen, Germany., Kowalewski DJ; Department of Immunology, Interfaculty Institute for Cell Biology, University of Tübingen, Tübingen, Germany., Freudenmann LK; Department of Immunology, Interfaculty Institute for Cell Biology, University of Tübingen, Tübingen, Germany.; Cluster of Excellence iFIT (EXC 2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tübingen, Germany.; DKFZ Partner Site Tübingen, German Cancer Consortium (DKTK), Tübingen, Germany., Backert L; Department of Immunology, Interfaculty Institute for Cell Biology, University of Tübingen, Tübingen, Germany.; Applied Bioinformatics, Department of Computer Science, University of Tübingen, Tübingen, Germany., Mühlenbruch L; Department of Immunology, Interfaculty Institute for Cell Biology, University of Tübingen, Tübingen, Germany.; Cluster of Excellence iFIT (EXC 2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tübingen, Germany.; DKFZ Partner Site Tübingen, German Cancer Consortium (DKTK), Tübingen, Germany., Szolek A; Applied Bioinformatics, Department of Computer Science, University of Tübingen, Tübingen, Germany., Lübke M; Department of Immunology, Interfaculty Institute for Cell Biology, University of Tübingen, Tübingen, Germany.; Cluster of Excellence iFIT (EXC 2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tübingen, Germany., Wagner P; Department of Immunology, Interfaculty Institute for Cell Biology, University of Tübingen, Tübingen, Germany.; Department of Obstetrics and Gynecology, University Hospital of Tübingen, Tübingen, Germany., Engler T; Department of Obstetrics and Gynecology, University Hospital of Tübingen, Tübingen, Germany., Matovina S; Department of Obstetrics and Gynecology, University Hospital of Tübingen, Tübingen, Germany., Wang J; Neuroimmunology and MS Research, Neurology Clinic, University Hospital Zurich, University of Zurich, Zurich, Switzerland., Hauri-Hohl M; Pediatric Stem Cell Transplantation, University Children's Hospital Zurich, Zurich, Switzerland., Martin R; Neuroimmunology and MS Research, Neurology Clinic, University Hospital Zurich, University of Zurich, Zurich, Switzerland., Kapolou K; Clinical Neuroscience Center and Department of Neurosurgery, University Hospital and University of Zurich, Zurich, Switzerland., Walz JS; Department of Immunology, Interfaculty Institute for Cell Biology, University of Tübingen, Tübingen, Germany.; Cluster of Excellence iFIT (EXC 2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tübingen, Germany.; Clinical Collaboration Unit Translational Immunology, German Cancer Consortium (DKTK), University Hospital of Tübingen, Tübingen, Germany.; Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology (IKP) and Robert Bosch Center for Tumor Diseases (RBCT), Stuttgart, Germany., Velz J; Clinical Neuroscience Center and Department of Neurosurgery, University Hospital and University of Zurich, Zurich, Switzerland., Moch H; Department of Pathology and Molecular Pathology, University Hospital and University of Zurich, Zurich, Switzerland., Regli L; Clinical Neuroscience Center and Department of Neurosurgery, University Hospital and University of Zurich, Zurich, Switzerland., Silginer M; Clinical Neuroscience Center and Department of Neurology, University Hospital and University of Zurich, Zurich, Switzerland., Weller M; Clinical Neuroscience Center and Department of Neurology, University Hospital and University of Zurich, Zurich, Switzerland., Löffler MW; Department of Immunology, Interfaculty Institute for Cell Biology, University of Tübingen, Tübingen, Germany.; Cluster of Excellence iFIT (EXC 2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tübingen, Germany.; DKFZ Partner Site Tübingen, German Cancer Consortium (DKTK), Tübingen, Germany.; Department of General, Visceral and Transplant Surgery, University Hospital of Tübingen, Tübingen, Germany.; Department of Clinical Pharmacology, University of Hospital Tübingen, Tübingen, Germany., Erhard F; Institute for Virology and Immunobiology, Julius-Maximilians-University Würzburg, Würzburg, Bayern, Germany., Schlosser A; Rudolf Virchow Center - Center for Integrative and Translational Bioimaging, Julius-Maximilians-University Würzburg, Würzburg, Germany., Kohlbacher O; Applied Bioinformatics, Department of Computer Science, University of Tübingen, Tübingen, Germany.; DKFZ Partner Site Tübingen, German Cancer Consortium (DKTK), Tübingen, Germany.; Institute for Bioinformatics and Medical Informatics, University of Tübingen, Tübingen, Germany.; Quantitative Biology Center (QBiC), University of Tübingen, Tübingen, Germany.; Biomolecular Interactions, Max Planck Institute for Developmental Biology, Tübingen, Germany.; Cluster of Excellence Machine Learning in the Sciences (EXC 2064), University of Tübingen, Tübingen, Germany.; Institute for Translational Bioinformatics, University Hospital Tübingen, Tübingen, Germany., Stevanović S; Department of Immunology, Interfaculty Institute for Cell Biology, University of Tübingen, Tübingen, Germany.; Cluster of Excellence iFIT (EXC 2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tübingen, Germany.; DKFZ Partner Site Tübingen, German Cancer Consortium (DKTK), Tübingen, Germany., Rammensee HG; Department of Immunology, Interfaculty Institute for Cell Biology, University of Tübingen, Tübingen, Germany.; Cluster of Excellence iFIT (EXC 2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tübingen, Germany.; DKFZ Partner Site Tübingen, German Cancer Consortium (DKTK), Tübingen, Germany., Neidert MC; Clinical Neuroscience Center and Department of Neurosurgery, University Hospital and University of Zurich, Zurich, Switzerland.; Department of Neurosurgery, Cantonal Hospital St.Gallen, St.Gallen, Switzerland.; Neuroscience Center Zurich (ZNZ), University of Zurich and ETH Zurich, Zurich, Switzerland.
Source: Journal for immunotherapy of cancer [J Immunother Cancer] 2021 Apr; Vol. 9 (4).
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101620585 Publication Model: Print Cited Medium: Internet ISSN: 2051-1426 (Electronic) Linking ISSN: 20511426 NLM ISO Abbreviation: J Immunother Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
Be the first to leave a comment!
You must be logged in first